ScoreWhy is Sino Medical Sciences Technology, Inc. ?
1
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of 14.80% and Operating profit at 29.84% over the last 5 years
- The company is Net-Debt Free
2
Poor long term growth as Net Sales has grown by an annual rate of 14.80% and Operating profit at 29.84% over the last 5 years
3
With a growth in Net Sales of 18.01%, the company declared Very Positive results in Jun 26
- The company has declared positive results for the last 7 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at CNY 203.66 MM
- NET PROFIT(HY) Higher at CNY 50.33 MM
- ROCE(HY) Highest at 8.86%
4
With ROE of 7.24%, it has a expensive valuation with a 7.65 Price to Book Value
- Over the past year, while the stock has generated a return of -43.67%, its profits have risen by 1120.3% ; the PEG ratio of the company is 0.1
5
Underperformed the market in the last 1 year
- Even though the market (China Shanghai Composite) has generated returns of 3.40% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -43.67% returns
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Sino Medical Sciences Technology, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Sino Medical Sciences Technology, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Sino Medical Sciences Technology, Inc.
-43.99%
0.94
61.15%
China Shanghai Composite
3.23%
0.23
14.72%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
14.80%
EBIT Growth (5y)
29.84%
EBIT to Interest (avg)
-48.82
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.15
Sales to Capital Employed (avg)
0.43
Tax Ratio
23.98%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.08%
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
106
Industry P/E
Price to Book Value
7.65
EV to EBIT
94.93
EV to EBITDA
50.23
EV to Capital Employed
9.88
EV to Sales
13.01
PEG Ratio
0.09
Dividend Yield
NA
ROCE (Latest)
10.41%
ROE (Latest)
7.24%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend29What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 203.66 MM
NET PROFIT(HY)
Higher at CNY 50.33 MM
ROCE(HY)
Highest at 8.86%
INTEREST COVERAGE RATIO(Q)
Highest at 5,516.91
RAW MATERIAL COST(Y)
Fallen by -14.69% (YoY
NET SALES(Q)
Highest at CNY 164.9 MM
OPERATING PROFIT(Q)
Highest at CNY 55.62 MM
PRE-TAX PROFIT(Q)
Highest at CNY 36.88 MM
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Sino Medical Sciences Technology, Inc.
Net Profit
At CNY 50.33 MM has Grown at 263.59%
Year on Year (YoY)MOJO Watch
Net Profit trend is very positive
Net Profit (CNY MM)
Operating Cash Flow
Highest at CNY 203.66 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Interest Coverage Ratio
Highest at 5,516.91
in the last five periodsMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Net Profit
Higher at CNY 50.33 MM
than preceding 12 month period ended Jun 2026MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (CNY MM)
Net Sales
Highest at CNY 164.9 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Net Sales
At CNY 164.9 MM has Grown at 16.89%
over average net sales of the previous four periods of CNY 141.07 MMMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Operating Profit
Highest at CNY 55.62 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (CNY MM)
Pre-Tax Profit
Highest at CNY 36.88 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Pre-Tax Profit
At CNY 36.88 MM has Grown at 56.11%
over average net sales of the previous four periods of CNY 23.62 MMMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Raw Material Cost
Fallen by -14.69% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Footer loading
